Beijing-based Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutical companies, announced that it has raised a US$15 million series B round of financing from Sequoia Capital China.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?